Compare GVA & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GVA | BIRK |
|---|---|---|
| Founded | 1922 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | 8000 |
| Industry | Military/Government/Technical | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.6B |
| IPO Year | 1995 | 2023 |
| Metric | GVA | BIRK |
|---|---|---|
| Price | $119.30 | $34.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $118.33 | $61.43 |
| AVG Volume (30 Days) | 440.5K | ★ 2.9M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | ★ 0.42% | N/A |
| EPS Growth | ★ 47.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,762,965,000.00 | N/A |
| Revenue This Year | $13.26 | $13.71 |
| Revenue Next Year | $6.92 | $14.30 |
| P/E Ratio | ★ N/A | $17.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $97.26 | $31.33 |
| 52 Week High | $162.08 | $50.73 |
| Indicator | GVA | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 40.95 | 35.98 |
| Support Level | $116.43 | $33.06 |
| Resistance Level | $129.07 | $37.29 |
| Average True Range (ATR) | 3.20 | 1.34 |
| MACD | -0.31 | -0.06 |
| Stochastic Oscillator | 15.11 | 4.01 |
Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. The company focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, dams, tunnels, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, and rest from Materials segment.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.